As of June 5, 2026, it is expected that BCP Asia AYM Holding (Cayman) L.P. will become a major shareholder following the acquisition of all shares of Ayumi Pharmaceutical Holdings. The transfer is scheduled between June 30 and September 30, 2026, with no impact on management or performance.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"2160","jir_company_name":"GN Air-Group Inc.","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-06-05","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/06\/2160-20260605-02.pdf","jir_short_summary":"As of June 5, 2026, it is expected that BCP Asia AYM Holding (Cayman) L.P. will become a major shareholder following the acquisition of all shares of Ayumi Pharmaceutical Holdings. The transfer is scheduled between June 30 and September 30, 2026, with no impact on management or performance.","jir_summary":"### Change in Shareholder Composition\nOn June 5, 2026, the Company completed the acquisition of all shares of Ayumi Pharmaceutical Holdings and the issuance of new shares through third-party allotment, with BCP Asia AYM Holding (Cayman) L.P. expected to become a major shareholder. As a result, the shareholder will hold 69,820 units (10.63%) of voting rights, resulting in changes in shareholder composition. The transfer is scheduled between June 30 and September 30, 2026, with no impact on management or performance.\n\n### Future Outlook and Impact\nThe shareholding change will not directly affect the company's management or business performance, and current operations will remain unaffected. Although the capital structure will change with the entry of a new shareholder, no modifications are expected to the company's management strategy or earnings forecasts.","jir_financial_highlights":"Number of voting rights owned by major shareholders: 69,820 units (6,982,004 shares) (Voting rights increase after new acquisition)\nPercentage of voting rights: 10.63% (0 shares before transfer, 10.63% after)\nScheduled transfer date: From June 30, 2026, to September 30, 2026 (As scheduled)","jir_category":"","jir_hashtags":"#GNAirGroup, #IRRelated, #JapaneseStocks","jir_key_figures":"Number of voting rights owned: 69,820 units (6,982,004 shares)\nPercentage of voting rights: 10.63%\nScheduled transfer period: From June 30, 2026, to September 30, 2026","jir_meta_title":"\u3010GN Air-Group\u3011Major Shareholder Change\uff5cJune 2026","jir_meta_description":"GN Air-Group Inc. will experience a change in major shareholders following the acquisition of Ayumi Pharmaceutical Holdings' stock in June 2026. We provide detailed information on the transfer period and its impact.","jir_og_title":"\u3010GN Air-Group\u3011Shareholder Change\uff5cJune 2026","jir_og_description":"In June 2026, the major shareholder of GN Air-Group will change. Detailed information on the transfer period and management implications is provided.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":9370,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"share_cancellation","footnotes":""},"sector":[],"importance":[],"class_list":["post-61922","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n